Requests For Opinions
Salicylic Acid: Request for SCCS opinion
Considering the concerns related to potential endocrine-disrupting properties of “Salicylic Acid” the European Commission has asked the Scientific Committee to assess its safety in cosmetic products. On 3 February 2022, this mandate has been accepted by the SCCS and the Committee has nine months to deliver its Opinion.

